ESTA
Establishment Labs Holdings Inc.
NASDAQ · CRHealthcareMedical - Devices
$93.42+0.91%
Price as of Jul 20, 2026
ESTA profitability
Establishment Labs Holdings Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 70.1%
- EBITDA margin
- -6.3%
- EBIT margin
- -12.4%
- Net margin
- -19.1%
- Free cash flow margin
- -18.4%
Returns
- Return on equity
- -295.9%
- Return on assets
- -12.5%
- Return on invested capital
- -10.3%
- Asset turnover
- 0.65x
Cash efficiency
- Cash from operations
- -$34.8M
- Cash per share
- $2.31
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.